This Phase 2 proof-of-concept, dose range finding study aims to evaluate the safety and efficacy of 3 dose levels of NMD670 vs placebo in adult patients with M…

Myasthenia GravisMyasthenia Gravis, MuSK

~Estimated

~$10 – $8,750

NMD Pharma A/SNCT06414954

AXIS Autoimmune Neurology Registry

The goal of the AXIS Autoimmune Neurology Registry is to learn about the experiences of adults living with autoimmune neurological disorders, starting with mya…

Myasthenia Gravis (MG)Myasthenia Gravis, GeneralizedMyasthenia Gravis, Ocular+12 more

~Estimated

~$10 – $1,125

Autoimmune Neurology AllianceNCT07761026

Myasthenia Gravis Foundation of America Global MG Patient Registry

The goal of this observational study is to learn about the experiences of people living with Myasthenia Gravis (MG) in the United States. The main questions it…

Myasthaenia GravisMyastheniaMyasthenia Gravis Associated with Thymoma+10 more

~Estimated

~$10 – $750

Myasthenia Gravis Foundation of AmericaNCT06617741